Atrial fibrillation clinical trials

Explore recruiting atrial fibrillation clinical trials.

Recruiting atrial fibrillation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Atrial fibrillation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A prospective, randomized, double- blind, placebo- controlled study to evaluate the efficacy of Landiolol hydrochloride for prevention of atrial fibrillation in patients undergoing cardiac surgery

Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Colchicine after Electrocardioversion for Atrial Fibrillation - The COLECTRO-AF Trial

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Germany, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A Multicenter, RandomiZed, Active-ControLled Study to Evaluate the Safety and Tolerability of Two Blinded Doses of Abelacimab (MAA868) Compared with Open-Label Rivaroxaban in Patients with Atrial Fibrillation (AZALEA)

Czechia, Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

GeranylGeranylAcetone as prevention for postoperative Atrial Fibrillation (GENIALITY)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Atrial fibrillation trials by city

Atrial fibrillation in Toronto Atrial fibrillation in Vancouver Atrial fibrillation in Montreal Atrial fibrillation in Calgary Atrial fibrillation in Edmonton Atrial fibrillation in Ottawa Atrial fibrillation in Winnipeg Atrial fibrillation in Quebec City Atrial fibrillation in Hamilton Atrial fibrillation in Kitchener Atrial fibrillation in London Atrial fibrillation in Halifax Atrial fibrillation in New York Atrial fibrillation in Los Angeles Atrial fibrillation in Chicago Atrial fibrillation in Houston

Other conditions

Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease IgA nephropathy Polycystic kidney disease Migraine Alzheimer's disease Parkinson's disease